A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.
Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...
News-Medical.Net on MSN
Light-based sensor can detect low concentrations of cancer biomarkers in the blood
Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer ...
Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the blood. The new technology could one day make it possible to ...
Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors learning to shrug off chemotherapy that once held them in check. A new wave of ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...
Researchers used CRISPR gene editing to selectively kill cancer cells with amplified oncogenes. In animal and cellular models ...
ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial ...
Schematic of the CRISPR/Cas9 system and its nanotechnology delivery methods. The CRISPR/Cas9 system can be delivered in the forms of DNA, mRNA/sgRNA, or ribonucleoprotein (RNP). The gene editing tools ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results